Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Giuliano, Simone ^a   Guastalegname, Maurizio ^a   Jenco, Miryam ^b   Morelli, Andrea ^a   Falcone, M Marco ^a   Venditti, Mario ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Bloodstream infections; Clostridium difficile; Fidaxomicin; Intestinal flora; Klebsiella pneumoniae; KPC

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEMASE; CEFDITOREN PIVOXIL; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; NORADRENALIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TAZOBACTAM; TIGECYCLINE; VANCOMYCIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; FIDAXOMICIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BLOOD CULTURE; BLOODSTREAM INFECTION; CASE REPORT; CAUSE OF DEATH; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTRACHEAL INTUBATION; ESCHERICHIA COLI INFECTION; FEVER; FLUID RESUSCITATION; HEALTHCARE ASSOCIATED INFECTION; HISTOLOGY; HOSPITAL READMISSION; HUMAN; HUMAN TISSUE; INTENSIVE CARE; INTESTINE FLORA; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LABORATORY DIAGNOSIS; LENGTH OF STAY; MALE; MEDICAL HISTORY; MIDDLE AGED; PSEUDOMEMBRANOUS COLITIS; SEPTIC SHOCK; TOXIC MEGACOLON; UNCONSCIOUSNESS; URINARY TRACT INFECTION; BACTEREMIA; BLOOD; CHEMISTRY; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; FATALITY; HOSPITAL; KLEBSIELLA INFECTION; MIXED INFECTION; MORTALITY; PEPTOCLOSTRIDIUM DIFFICILE;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COINFECTION; CROSS INFECTION; FATAL OUTCOME; HOSPITALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED;

EID: 84908060593     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-475     Document Type: Article

References (17)

1. Pournaras S, Poulou A, Tsakris A: Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds. J Antimicrob Chemother 2010, 65(7):1319-1321.
2. European Centre for Disease Prevention and Control: Antimicrobial resistance surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2013.
3. Corcione S, Cardellino CS, Calcagno A, Fossati L, Costa C, Cavallo R, Di Perri G, De Rosa FG: Healthcare-associated Klebsiella pneumoniae Carbapenemase producing K. pneumoniae bloodstream infection: the time has come. Clin Infect Dis 2014, 59(2):321-322.
4. Capone A, Giannella M, Fortini D, Giordano A, Meledandri M, Ballardini M, Venditti M, Bordi E, Capozzi D, Balice MP, Tarasi A, Parisi G, Lappa A, Carattoli A, Petrosillo N, SEERBIO-GRAB network: High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect 2013, 19(1):E23-E30.
5. Di Bella S, Musso M, Cataldo MA, Meledandri M, Bordi E, Capozzi D, Cava MC, Chiaradonna P, Prignano G, Petrosillo N: Clostridium difficile infection in Italian urban hospitals. Data from 2006 through 2011. BMC Infect Dis 2013, 13(1):146.
6. Guastalegname M, Grieco S, Giuliano S, Falcone M, Caccese R, Carfagna P, D'ambrosio M, Taliani G, Venditti M: A cluster of fulminant Clostridium difficile colitis in an intensive care unit in Italy. Infection 2014, 42(3):585-589.
7. Di Bella S, Paglia MG, Johnson E, Petrosillo N: Clostridium difficile 027 infection in Central Italy. BMC Infect Dis 2012, 12:370.1.
8. Orsi GB, Conti C, Mancini C, Giordano A: Clostridium difficile 027 increasing detection in a teaching hospital in Rome, Italy. Infection 2014, [Epub ahead of print].
9. Guastalegname M, Russo A, Falcone M, Giuliano S, Venditti M: Candidemia subsequent to severe infection due to Clostridium difficile: is there a link? Clin Infect Dis 2013, 57:772-774.
10. Perez F, Pultz MJ, Endimiani A, Bonomo RA, Donskey CJ: Effect of antibiotic treatment on establishment and elimination of intestinal colonization by KPC-Producing Klebsiella pneumoniae in mice. Antimicrob Agents Chemother 2011, 55(6):2585-2589.
11. Edlund C, Barkholt L, Olsson-Liljequist B, Nord CE: Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy. Clin Infect Dis 1997, 25(3):729-732.
12. Richter SN, Frasson I, Franchin E, Bergo C, Lavezzo E, Cavallaro A, Palù G: KPC-mediated resistance in Klebsiella pneumoniae in two hospitals in Padua, Italy, June 2009-December 2011: massive spreading of a KPC-3-encoding plasmid and involvement of non-intensive care units. Gut Pathog 2012, 4(1):7.
13. Louie TJ, Cannon K, Byrne B, Emery J, Ward L, Eyben M, Krulicki W: Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. Clin Infect Dis 2012, 55(Suppl 2):S132-S142.
14. Johansson ME, Gustafsson JK, Holmén-Larsson J, Jabbar KS, Xia L, Xu H, Ghishan FK, Carvalho FA, Gewirtz AT, Sjövall H, Hansson GC: Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 2014, 63 (2):281-291.
15. Mainous MR, Tso P, Berg RD, Deitch EA: Studies of the route, magnitude, and time course of bacterial translocation in a model of systemic inflammation. Arch Surg 1991, 126(1):33-37.
16. Eaves-Pyles T, Alexander JW: Comparison of translocation of different types of microorganisms from the intestinal tract of burned mice. Shock 2001, 16(2):148-152.
17. Nerandzic MM, Mullane K, Miller MA, Babakhani F, Donskey CJ: Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection. Clin Infect Dis 2012, 55(S2):S121-S126.